Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q2 EPS
Tweet Send to a FriendGet Alerts RIGL Hot Sheet
Price: $3.77 --0%
Revenue Growth %: -100.0%
Financial Fact:
General and administrative: 5.4M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -100.0%
Financial Fact:
General and administrative: 5.4M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade RIGL Now!
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $1.15 million versus the consensus estimate of $550 thousand.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- China Cord Blood Corp. (CO) Tops Q4 EPS by 3c
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
